RongCan’s Pilot Test Base in Minhang Guanghua Industrial Park Was Officially Put into Operation

Focusing on the development and industrialization of nucleic acid medicines

Focusing on the development and industrialization of nucleic acid medicines

Focusing on the development and industrialization of nucleic acid medicines

Possesses a proprietary RNA-based Therapeutic Platform (RTP) independently developed for nucleic acid medicines

RongCan’s Pilot Test Base in Minhang Guanghua Industrial Park Was Officially Put into Operation

Date : 2021-10-15

Prev : RongCan Biotech Plans to Cooperate with Zhangjiang Hi-tech Park to Set Up a Management Headquarter

Next : RongCan Biotech Won the Second Prize at the Anhui Selective Trial of China Innovation and Entrepreneurship Competition